Loss of nuclear cyclic AMP binding in cyclic AMP-unresponsive Walker 256 mammary carcinoma.
D000818:Animals; D003994:Bucladesine / Q000627:therapeutic use*; D002279:Carcinoma 256, Walker / Q000188:drug therapy / Q000378:metabolism*; D002467:Cell Nucleus / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism; D004351:Drug Resistance; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism; D011458:Prostaglandins E / Q000494:pharmacology; D011494:Protein Kinases / Q000378:metabolism; D051381:Rats; D011953:Receptors, Cyclic AMP / Q000378:metabolism*
D011458:Prostaglandins E; D011953:Receptors, Cyclic AMP; D003994:Bucladesine; D011494:Protein Kinases